By week 24 (approximately 6 months), the average weight reduction was up to 17.5%, and this continued to increase through to week 48, reaching up to 24.2%
Others are looking at alternative ways to stabilise GLP-1 drugs that might prove easier to produce
How does it feel to take GLP-1s
Retatrutide is a next-generation triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, making it one of the most studied compounds in modern metabolic peptide research
Sit still, breathe through your nose, and let the medication do its work
For more information, call Wellmark at the number on your ID card or call Wellmark Customer Service